Suchergebnis | Hamburg Open Science

Facetten

29 Einträge gefunden

[Type and extent of preoperative imaging before radical prostatectomy].
2010 - Forschungsinformationssystem des UKE
Prognostic significance of a positive surgical margin in pathologically organ-confined prostate cancer.
2010 - Forschungsinformationssystem des UKE
Importance of baseline potency rate assessment of men diagnosed with clinically localized prostate cancer prior to radical prostatectomy.
2009 - Forschungsinformationssystem des UKE
Current Technique of Open Intrafascial Nerve-Sparing Retropubic Prostatectomy.
2009 - Forschungsinformationssystem des UKE
Head-to-head comparison of the three most commonly used preoperative models for prediction of biochemical recurrence after radical prostatectomy.
2009 - Forschungsinformationssystem des UKE
Long-term data on the survival of patients with prostate cancer treated with radical prostatectomy in the prostate-specific antigen era.
2009 - Forschungsinformationssystem des UKE
Marked gene transcript level alterations occur early during radical prostatectomy.
2008 - Forschungsinformationssystem des UKE
Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower.
2008 - Forschungsinformationssystem des UKE
Assessment of pathological prostate cancer characteristics in men with favorable biopsy features on predominantly sextant biopsy.
2008 - Forschungsinformationssystem des UKE
Distinct subcellular expression patterns of neutral endopeptidase (CD10) in prostate cancer predict diverging clinical courses in surgically treated patients.
2008 - Forschungsinformationssystem des UKE
Comparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancer.
2007 - Forschungsinformationssystem des UKE
Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy.
2007 - Forschungsinformationssystem des UKE
Zonal origin of localized prostate cancer does not affect the rate of biochemical recurrence after radical prostatectomy.
2007 - Forschungsinformationssystem des UKE
[DNA methylation on urinalysis and as a prognostic marker in urothelial cancer of the bladder]
2007 - Forschungsinformationssystem des UKE
Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancer.
2007 - Forschungsinformationssystem des UKE
Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology.
2006 - Forschungsinformationssystem des UKE
Validation of a nomogram for prediction of side specific extracapsular extension at radical prostatectomy.
2006 - Forschungsinformationssystem des UKE
Comparative assessment of the 1992 and 2002 pathologic T3 substages for the prediction of biochemical recurrence after radical prostatectomy.
2006 - Forschungsinformationssystem des UKE
Development and internal validation of preoperative transition zone prostate cancer nomogram.
2006 - Forschungsinformationssystem des UKE
Risk assessment for biochemical recurrence prior to radical prostatectomy: significant enhancement contributed by human glandular kallikrein 2 (hK2) and free prostate specific antigen (PSA) in men with moderate PSA-elevation in serum.
2006 - Forschungsinformationssystem des UKE

Aktive Facetten

Facetten

Zugriff

Einrichtung

Medientyp

Karte

Erscheinungsjahr

Autor/in

Sprache

[Type and extent of preoperative imaging before radical prostatectomy].

Prognostic significance of a positive surgical margin in pathologically organ-confined prostate cancer.

Importance of baseline potency rate assessment of men diagnosed with clinically localized prostate cancer prior to radical prostatectomy.

Current Technique of Open Intrafascial Nerve-Sparing Retropubic Prostatectomy.

Head-to-head comparison of the three most commonly used preoperative models for prediction of biochemical recurrence after radical prostatectomy.

Long-term data on the survival of patients with prostate cancer treated with radical prostatectomy in the prostate-specific antigen era.

Marked gene transcript level alterations occur early during radical prostatectomy.

Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower.

Assessment of pathological prostate cancer characteristics in men with favorable biopsy features on predominantly sextant biopsy.

Distinct subcellular expression patterns of neutral endopeptidase (CD10) in prostate cancer predict diverging clinical courses in surgically treated patients.

Comparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancer.

Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy.

Zonal origin of localized prostate cancer does not affect the rate of biochemical recurrence after radical prostatectomy.

[DNA methylation on urinalysis and as a prognostic marker in urothelial cancer of the bladder]

Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancer.

Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology.

Validation of a nomogram for prediction of side specific extracapsular extension at radical prostatectomy.

Comparative assessment of the 1992 and 2002 pathologic T3 substages for the prediction of biochemical recurrence after radical prostatectomy.

Development and internal validation of preoperative transition zone prostate cancer nomogram.

Risk assessment for biochemical recurrence prior to radical prostatectomy: significant enhancement contributed by human glandular kallikrein 2 (hK2) and free prostate specific antigen (PSA) in men with moderate PSA-elevation in serum.